Company Performance Metrics
- Robert Goldman: Co-Founder & President
- Jenean Kirby: Chief Operating Officer of Corporate Affairs and General CounselPast Role: Rutgers University School of Law, Adjunct Faculty
PeproTech was established in 1988 by a group of scientists who decided to focus their efforts on the development and production of recombinant cytokines for life-science research. Today, PeproTech is a world leader in supplying high quality cytokine products including E.coli, insect, and mammalian cell-derived recombinant proteins, their
monoclonal/polyclonal antibodies, ELISA Development Kits, Cell Culture Media/Supplements, and other cytokine-related reagents. These products are distributed worldwide through customer-service offices in the US, UK, France, Germany, Israel, Korea, China, Japan, Brazil, and Mexico. They plan to maintain the highly competitive price of their products and to expand their distribution to Australia, New Zealand, and other locations. To keep up with current research and growing demand they have expanded their production capabilities to include a 5000 sq. ft. animal-free manufacturing facility. A key component in keeping up with current scientific advancements has been their collaboration with researchers in both academia and industry who provide us with suggestions necessary to continuously expand their product pipeline. They encourage you to convey to us your particular research needs and promise to do their best to fulfill them.
